ArticleBMJ open2022

Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B).

Rie Ozeki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.